© 1995 American Heart Association, Inc.
Articles |
Quantification of Myotrophin From Spontaneously Hypertensive and Normal Rat Hearts
From the Department of Molecular Cardiology, Research Institute, The Cleveland (Ohio) Clinic Foundation.
Correspondence to Subha Sen, PhD, DSc, Department of Molecular Cardiology, Research Institute, FF4-09, The Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195. E-mail sens@ccsmtp.ccf.org.
Abstract A novel peptide, myotrophin, has been isolated, purified, cloned, and sequenced from the hearts of spontaneously hypertensive rats (SHR) and from dilated cardiomyopathic human heart tissue. Myotrophin accelerates myocyte growth by stimulating protein synthesis (not by altering myocardial cell division). Our successive studies were conducted to evaluate the pathophysiological significance of myotrophin; a solid-phase radioimmunoassay technique was developed for quantifying the protein in hypertrophied and normal hearts. Specific antipeptide antibody was raised in rabbits against a peptide that represents a selected amino acid sequence of a 17–amino acid myotrophin segment by using the multiple antigenic peptide technique. The specificity of the antibody was evaluated by determining the affinity constant after constructing the Scatchard plot obtained from the ratio of bound to free myotrophin against bound myotrophin. The value obtained was 2.61x107 L/mol. The specificity was further demonstrated by Western blot analysis, in which a single protein band was obtained in the region of 12 kD. Pretreatment of the antibody with myotrophin completely blocked the binding sites, because no protein band was detected on the immunoblot. The antibody prevented the myocardial protein synthesis induced by myotrophin as revealed by the blockage of the stimulation of [3H]leucine incorporation into myocyte protein. Quantification of myotrophin from different heart tissues was achieved by Western blot and dot blot analyses. Amounts of myotrophin present in different dots were determined by using a video image analyzer. The level of myotrophin in the embryonic tissue was found to be similar in male normal and SHR hearts. The level of myotrophin concentration then starts increasing by as early as 3 days of age in SHR. In 9-day-old SHR, the change is statistically significant. In 4-, 8-, 11-, and 17-week-old SHR, myotrophin concentration increased linearly and significantly compared with age- and sex-matched normal control rats. No detectable amount of myotrophin was found in kidney or lung. Our data suggest that myotrophin may play an important role in the pathogenesis of cardiac hypertrophy.
Key Words: multiple antigenic peptide • affinity constant • hypertensive hypertrophy • myotrophin • spontaneously hypertensive rats
This article has been cited by other articles:
 |
|
 |
|
  S. Sarkar, D. W. Leaman, S. Gupta, P. Sil, D. Young, A. Morehead, D. Mukherjee, N. Ratliff, Y. Sun, M. Rayborn, et al. Cardiac Overexpression of Myotrophin Triggers Myocardial Hypertrophy and Heart Failure in Transgenic Mice J. Biol. Chem., May 7, 2004; 279(19): 20422 - 20434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gupta, N. H. Purcell, A. Lin, and S. Sen Activation of nuclear factor-{kappa}B is necessary for myotrophin-induced cardiac hypertrophy J. Cell Biol., December 23, 2002; 159(6): 1019 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Knuefermann, P. Chen, A. Misra, S.-P. Shi, M. Abdellatif, and N. Sivasubramanian Myotrophin/V-1, a Protein Up-regulated in the Failing Human Heart and in Postnatal Cerebellum, Converts NFkappa B p50-p65 Heterodimers to p50-p50 and p65-p65 Homodimers J. Biol. Chem., June 21, 2002; 277(26): 23888 - 23897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sivasubramanian, G. Adhikary, P. C. Sil, and S. Sen Cardiac Myotrophin Exhibits rel/NF-kappaB Interacting Activity in Vitro J. Biol. Chem., February 2, 1996; 271(5): 2812 - 2816. [Abstract] [Full Text] [PDF]
|
|